1
William M Yen, Weiyi Jia, Lizhu Lu, Huabiao Yuan: Long-persistence blue phosphors. University of Georgia Research Foundation, University of Puerto Rico, Greenlee Winner and Sullivan P C, September 12, 2000: US06117362 (164 worldwide citation)

This invention relates to phosphors including long-persistence blue phosphors. Phosphors of the invention are represented by the general formula:


2
William M Yen, Dongdong Jia, Weiyi Jia, Xiao jun Wang: Long persistent phosphors and persistent energy transfer technique. University of Georgia Research Foundation, Thomas Kayden Horstemeyer & Risley, October 11, 2005: US06953536 (129 worldwide citation)

The invention provides long-persistent phosphors, methods for their manufacture and phosphorescent articles. The invention also provides a method for generating a long-persistent phosphorescence at a selected color. The phosphors of the invention may be alkaline earth aluminates, alkaline earth sili ...


3
Renee Kaswan: Method of increasing tear production by topical administration of cyclosporin. University of Georgia Research Foundation, Kilpatrick & Cody, June 13, 1989: US04839342 (116 worldwide citation)

The present invention provides a method of treating an aqueous-deficient dry eye state in a patient suffering therefrom, which method includes the step of administering cyclosporin topically to the patient's eye. The cyclosporin is administered as a solution, suspension or ointment in a pharmaceutic ...


4
Raymond F Schinazi, Dennis C Liotta, Chung K Chu, J Jeffrey McAtee, Junxing Shi, Yongseok Choi, Kyeong Lee, Joon H Hong: 2′-Fluoronucleosides. Emory University, University of Georgia Research Foundation, Sherry M Knowles Esq, Josephine Young, King & Spalding, February 19, 2002: US06348587 (115 worldwide citation)

A class of 2′-fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular proliferation, including tumors and cancer. The compounds have the general formulae:


5
Milton J Cormier, William W Lorenz: Isolated Renilla luciferase and method of use thereof. University of Georgia Research Foundation, Jones & Askew, May 23, 1995: US05418155 (98 worldwide citation)

Genetic material encoding luciferase from the marine coelenterate Renilla has been isolated and characterized. This genetic material allows the production of peptides for use as labels in bioluminescence assays or can itself be directly used to identify luciferase genes from related organisms.


6
Bernd J Meyer, Jeffrey P Sellers, Jan U Thomsen: Neural network system and methods for analysis of organic materials and structures using spectral data. University of Georgia Research Foundation, Kilpatrick & Cody, June 8, 1993: US05218529 (94 worldwide citation)

Apparatus and processes for recognizing and identifying materials. Characteristic spectra are obtained for the materials via spectroscopy techniques including nuclear magnetic resonance spectroscopy, infrared absorption analysis, x-ray analysis, mass spectroscopy and gas chromatography. Desired port ...


7
Milton J Cormier, William W Lorenz: Cloning and expressions of Renilla luciferase. University of Georgia Research Foundation Boyd Graduate Studies Research Center, Jones & Askew, March 8, 1994: US05292658 (90 worldwide citation)

Genetic material encoding luciferase from the marine coelenterate Renilla has been isolated and characterized. This genetic material allows the production of peptides for use as labels in bioluminescence assays or can itself be directly used to identify luciferase genes from related organisms.


8
Renee Kaswan: Ophthalmic treatment by topical administration of cyclosporin. University of Georgia Research Foundation, Oblon Fisher Spivak McClelland & Maier, March 10, 1987: US04649047 (85 worldwide citation)

The present invention relates to a method for the treatment of either phacoanaphylactic endophthalmitis or uveitis by administering at least one cyclosporin topically to the eyes. Topical application of cyclosporin provides cyclosporin to the anterior chamber, the posterior chamber and the vitreous ...


9
Ravi R Gokarn, Mark A Eiteman, Elliot Altman: Metabolically engineered E. coli for enhanced production of oxaloacetate-derived biochemicals. The University of Georgia Research Foundation, Mueting Raasch & Gebhardt P A, September 24, 2002: US06455284 (80 worldwide citation)

Metabolic engineering is used to increase the carbon flow toward oxaloacetate to enhance production of bulk biochemicals, such as lysine and succinate, in bacterial fermentations. Carbon flow is redirected by genetically engineering the cells to overexpress the enzyme pyruvate carboxylase.


10
Renee Kaswan: Ocular cyclosporine composition. University of Georgia Research Foundation, Kilpatrick & Cody, May 2, 1995: US05411952 (75 worldwide citation)

Cyclosporine compositions for topical ophthalmic use for treatment of immune disorders, to enhance or restore tear production, and to enhance or effect normal healing of the surface of the eye, containing cyclosporine dissolved in corn oil. The composition may further include antioxidants, lubricant ...



Click the thumbnails below to visualize the patent trend.